Cortese, Samuele http://orcid.org/0000-0001-5877-8075
Newcorn, Jeffrey H. http://orcid.org/0000-0001-8993-9337
Coghill, David http://orcid.org/0000-0003-3017-9737
Article History
Accepted: 16 July 2021
First Online: 17 August 2021
Declarations
:
: Not applicable.
: SC declares honoraria and reimbursement for travel and accommodation expenses for lectures from the following non-profit associations: Association for Child and Adolescent Central Health (ACAMH), Canadian ADHD Alliance Resource (CADDRA), British Association of Pharmacology (BAP), and the Healthcare Convention for educational activity on ADHD. In the past year, JN has been an advisor and/or consultant for Adlon Therapeutics, Arbor, Cingulate Therapeutics, Corium, Eisai, Lundbeck, Medice, Myriad Neuroscience, NLS, OnDosis, Rhodes, Shire/Takeda, and Supernus. He has received research support from the National Institute on Drug Abuse (NIDA), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Adlon, Shire and Supernus. He also has received speaker fees from Shire/Takeda for disease-state presentations and has served as a consultant for the US National Football League. DC has received research support from the National Health and Medical Research Council (NHMRC) Australia, research support and/or honoraria from Shire/Takeda, Medice, and Servier, and royalties from Oxford University Press and Cambridge University Press.
: Not applicable.
: Not applicable.
: SC drafted the first version of the manuscript; JN and DC revised it critically. All authors read and approved the final version of the manuscript for submission and publication, and all agree to be accountable for the review.
: Not applicable.
: Not applicable.
: Not applicable.